Financials
- Market Capitalization 209.74 M
- Employee 854
- Founded N/A
- CEO Gary S. Gillheeney Sr.
- Website www.organogenesis.com
- Headquarter Delaware, United States
- FIGI BBG00FGGD295
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.08
Relación precio/flujo de caja
0.69
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3519 | SIGA SIGA Technologies Inc. - Common Stock | 3.16 USD | +0.64% | +4.29% | -4.53% | -62.82% | 227.05 M USD | ||
| 3569 | DERM Journey Medical Corporation - Common Stock | 7.54 USD | +1.75% | -2.33% | +18.37% | +5.75% | 212.81 M USD | ||
| 3601 | CRDL Cardiol Therapeutics Inc. - Class A Common Shares | 2.02 USD | +2.02% | +1.51% | +56.59% | +85.32% | 202.52 M USD | ||
| 3692 | LFCR Lifecore Biomedical, Inc. - Common Stock | 4.40 USD | -1.35% | -3.93% | -2.22% | -41.10% | 166.55 M USD |